
    
      This is a multicentre, descriptive, observational and ambispective study carried out in
      patients who are treated with Elbasvir/Grazoprevir in hospitals that included their data in
      Hepa-C Registry (directed by the Spanish Association for the Study of the Liver and the
      Networked Biomedical Research Centre for Hepatic and Digestive Diseases)
    
  